Studies on anti-angiogenesis of ginsenoside structure modification HRG in vitro

This study investigates the anti-angiogenic effect of 3β, 12β, 20(S)-trihydroxy dammarane-3-O-β-d-glucopyranosyl(1–2)-β-d-glucopyranoside(HRG), a new chemical compound obtained by structure modification on Ginseng saponins Rg3, associated with the regulation of matrix metalloproteinases(MMPs) and it...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 492; no. 3; pp. 391 - 396
Main Authors Li, Ji-ping, Zhao, Feng-li, Yuan, Ye, Sun, Ting-ting, Zhu, Lei, Zhang, Wen-you, Liu, Mo-xiang
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 21.10.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study investigates the anti-angiogenic effect of 3β, 12β, 20(S)-trihydroxy dammarane-3-O-β-d-glucopyranosyl(1–2)-β-d-glucopyranoside(HRG), a new chemical compound obtained by structure modification on Ginseng saponins Rg3, associated with the regulation of matrix metalloproteinases(MMPs) and its upstream signal-regulated molecule of vascular endothelial growth factor(VEGF) and basic fibroblast growth factor(b-FGF) in vitro, which plays an critical role in angiogenesis during the process of carcinoma. In our study, to investigate the anti-angiogenesis effect of HRG in HUVECs, we utilized cell proliferation assay, tube formation assay, wound-healing assay, Semi-quantitative reverse transcription PCR, and Western blot assay. Our results demonstrated that HRG plays a major role in the regulation of proliferation, migration and tube formation of HUVECs by suppressing the expression of VEGF and b-FGF in both transcriptional and post-transcriptional levels. In addition, the expression of MMP-2 and MMP-9, which were related to the ECM degradation, were down-regulated after administration of HRG as well. Overall, our results revealed that HRG strongly inhibited the process of angiogenesis and shows better effectiveness than Rg3.
AbstractList This study investigates the anti-angiogenic effect of 3β, 12β, 20(S)-trihydroxy dammarane-3-O-β-d-glucopyranosyl(1-2)-β-d-glucopyranoside(HRG), a new chemical compound obtained by structure modification on Ginseng saponins Rg3, associated with the regulation of matrix metalloproteinases(MMPs) and its upstream signal-regulated molecule of vascular endothelial growth factor(VEGF) and basic fibroblast growth factor(b-FGF) in vitro, which plays an critical role in angiogenesis during the process of carcinoma. In our study, to investigate the anti-angiogenesis effect of HRG in HUVECs, we utilized cell proliferation assay, tube formation assay, wound-healing assay, Semi-quantitative reverse transcription PCR, and Western blot assay. Our results demonstrated that HRG plays a major role in the regulation of proliferation, migration and tube formation of HUVECs by suppressing the expression of VEGF and b-FGF in both transcriptional and post-transcriptional levels. In addition, the expression of MMP-2 and MMP-9, which were related to the ECM degradation, were down-regulated after administration of HRG as well. Overall, our results revealed that HRG strongly inhibited the process of angiogenesis and shows better effectiveness than Rg3.
Author Sun, Ting-ting
Liu, Mo-xiang
Zhu, Lei
Yuan, Ye
Li, Ji-ping
Zhang, Wen-you
Zhao, Feng-li
Author_xml – sequence: 1
  givenname: Ji-ping
  surname: Li
  fullname: Li, Ji-ping
  email: jipingli2005@126.com
  organization: Department of Pharmacology, Medical College, Yangzhou University, Yangzhou 225001, Jiangsu, China
– sequence: 2
  givenname: Feng-li
  surname: Zhao
  fullname: Zhao, Feng-li
  organization: Department of Pharmacology, Medical College, Yangzhou University, Yangzhou 225001, Jiangsu, China
– sequence: 3
  givenname: Ye
  surname: Yuan
  fullname: Yuan, Ye
  organization: Department of Pharmacology, Medical College, Yangzhou University, Yangzhou 225001, Jiangsu, China
– sequence: 4
  givenname: Ting-ting
  surname: Sun
  fullname: Sun, Ting-ting
  organization: Department of Pharmacology, Medical College, Yangzhou University, Yangzhou 225001, Jiangsu, China
– sequence: 5
  givenname: Lei
  surname: Zhu
  fullname: Zhu, Lei
  organization: Department of Pharmacology, Medical College, Yangzhou University, Yangzhou 225001, Jiangsu, China
– sequence: 6
  givenname: Wen-you
  surname: Zhang
  fullname: Zhang, Wen-you
  organization: Department of Pharmacology, Medical College, Yangzhou University, Yangzhou 225001, Jiangsu, China
– sequence: 7
  givenname: Mo-xiang
  surname: Liu
  fullname: Liu, Mo-xiang
  organization: Institute of Drug Research, Medical College, Yangzhou University, Yangzhou 225001, Jiangsu, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28847727$$D View this record in MEDLINE/PubMed
BookMark eNp9kM1q3DAUhUVIaSZpXyCL4mU3dvVnW4JuSkiTQKClTaA7IV9dDxpmpFSSA32bPkueLBomzbKrC4fvHLjfKTkOMSAh54x2jLLh06abpgQdp2zsqOqopkdkxeppOaPymKwopUPLNft1Qk5z3lDKmBz0W3LClZLjyMcV-f6zLM5jbmJobCi-tWHt4xoDZl_DuVn7kDHE7B02uaQFypKw2UXnZw-2-Nq7_nHV-PD099GXFN-RN7PdZnz_cs_I_dfLu4vr9vbb1c3Fl9sWRD-UVjI20VFJDSA0Az1z7DnYHpWYa9T3sxI9tXJwdgAnpZhgBJDKDbNQfNDijHw87D6k-HvBXMzOZ8Dt1gaMSzZMC9HrUaixovyAQoo5J5zNQ_I7m_4YRs3epNmYvUmzN2moMlVhLX142V-mHbrXyj91Ffh8ALB--egxmQweA6DzCaEYF_3_9p8BT1SHyQ
CitedBy_id crossref_primary_10_1016_j_jgr_2020_07_002
crossref_primary_10_1016_j_jgr_2022_08_003
crossref_primary_10_1007_s10529_022_03243_0
crossref_primary_10_3390_molecules25214905
crossref_primary_10_1016_j_bioorg_2021_105535
crossref_primary_10_3390_cancers13092223
crossref_primary_10_3389_fphar_2018_00423
crossref_primary_10_5650_jos_ess23120
Cites_doi 10.1016/j.ccr.2013.02.019
10.1097/00000658-197203000-00014
10.1007/s10456-009-9134-8
10.1159/000318806
10.1038/sj.bjc.6603813
10.1074/jbc.274.50.35562
10.1016/S0968-0004(97)01074-8
10.1016/j.biopha.2017.02.038
10.2174/187152012800228706
10.1002/med.20101
10.1002/jcb.1190
10.1016/j.mvr.2007.05.006
10.1023/A:1018491314066
10.1002/ijc.21421
10.1016/j.bcp.2011.12.039
10.2147/CMAR.S77400
10.1016/j.ctrv.2013.01.004
10.1615/CritRevOncog.2014012378
10.1248/yakushi1947.112.11_856
10.1038/nrc909
10.1016/j.ejphar.2011.07.029
ContentType Journal Article
Copyright 2017 Elsevier Inc.
Copyright © 2017 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2017 Elsevier Inc.
– notice: Copyright © 2017 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.bbrc.2017.08.090
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1090-2104
EndPage 396
ExternalDocumentID 10_1016_j_bbrc_2017_08_090
28847727
S0006291X17316492
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-~X
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABYKQ
ACDAQ
ACGFO
ACGFS
ACNCT
ACRLP
ADBBV
ADEZE
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
D0L
DM4
DOVZS
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
K-O
KOM
L7B
LG5
LX2
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
RNS
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSU
SSZ
T5K
TWZ
WH7
XPP
XSW
ZA5
ZMT
~02
~G-
AAHBH
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
.55
.GJ
.HR
1CY
3O-
9M8
AAQXK
AAYJJ
AAYXX
ABEFU
ABXDB
ACKIV
ADFGL
ADIYS
ADMUD
AFJKZ
AGRDE
AHHHB
ASPBG
AVWKF
AZFZN
CAG
CITATION
COF
FEDTE
FGOYB
G-2
G8K
HLW
HVGLF
HZ~
MVM
OHT
R2-
SBG
SEW
UQL
WUQ
X7M
Y6R
ZGI
ZKB
~KM
7X8
ID FETCH-LOGICAL-c356t-411b07849cc391c9f2e52ca5e83fcc355f8350a46da6cd443bc7cc48d6f382693
IEDL.DBID AIKHN
ISSN 0006-291X
IngestDate Fri Aug 16 08:06:34 EDT 2024
Thu Sep 26 16:29:00 EDT 2024
Sat Sep 28 08:48:24 EDT 2024
Fri Feb 23 02:19:57 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Ginsenoside structure modification
Cell proliferation
Angiogenesis
Migration
VEGF
HUVECs
Language English
License Copyright © 2017 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c356t-411b07849cc391c9f2e52ca5e83fcc355f8350a46da6cd443bc7cc48d6f382693
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 28847727
PQID 1933597387
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1933597387
crossref_primary_10_1016_j_bbrc_2017_08_090
pubmed_primary_28847727
elsevier_sciencedirect_doi_10_1016_j_bbrc_2017_08_090
PublicationCentury 2000
PublicationDate 2017-10-21
PublicationDateYYYYMMDD 2017-10-21
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-21
  day: 21
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Biochemical and biophysical research communications
PublicationTitleAlternate Biochem Biophys Res Commun
PublicationYear 2017
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Liu (bib17) 2000; 27
Lin, Piao, Li (bib15) 2002; 29
Carmeliet, Collen (bib23) 1999
Chen, Han (bib9) 2008; 28
Economopoulou, Kotsakis, Kapiris (bib6) 2015; 7
Naldini, Filippi, Cini (bib3) 2012; 12
Pang, Wang, Fu (bib19) 2001; 36
Goodwin (bib22) 2007; 74
Solov'Eva, Timoshenko, Kugaevskaia (bib31) 2014; 40
Liu, Cui, Zhao (bib20) 2013; 44
Iishi, Tatsuta, Baba (bib11) 1997; 15
Cavallaro, Tenan, Castelli (bib24) 2001; 82
Kamba, Mcdonald (bib10) 2007; 96
Bussolino, Mantovani, Persico (bib25) 1997; 22
Bo, Wang, Yan (bib12) 2014; 7
Mabeta, Pepper (bib4) 2009; 12
Wang, So, Reierstad (bib29) 2006; 118
Bono, Smet, Herbert (bib8) 2013; 23
Lyu, Zhao, Li (bib16) 2014; 24
Tong, Matsuda, Kubo (bib14) 1992; 112
Pratheeshkumar, Kuttan (bib28) 2011; 668
Ashton, Yokota, John (bib21) 1999; 274
Funakoshi, Latif, Galsky (bib5) 2013; 39
Erdozain, Pegrum, Winrow (bib27) 2011; 48
Kwok, Guo, Lau (bib13) 2012; 83
Silletti, Kessler, Goldberg (bib30) 2001; 98
Arrighetti, Corno, Gatti (bib2) 2015; 20
Folkman (bib1) 1972; 175
Elhalawani, Abdelrahman (bib7) 2015; 11
Yuan, Hao, Zhu (bib18) 2017; 89
Ferrara (bib26) 2002; 2
Economopoulou (10.1016/j.bbrc.2017.08.090_bib6) 2015; 7
Cavallaro (10.1016/j.bbrc.2017.08.090_bib24) 2001; 82
Erdozain (10.1016/j.bbrc.2017.08.090_bib27) 2011; 48
Lin (10.1016/j.bbrc.2017.08.090_bib15) 2002; 29
Lyu (10.1016/j.bbrc.2017.08.090_bib16) 2014; 24
Pang (10.1016/j.bbrc.2017.08.090_bib19) 2001; 36
Silletti (10.1016/j.bbrc.2017.08.090_bib30) 2001; 98
Iishi (10.1016/j.bbrc.2017.08.090_bib11) 1997; 15
Elhalawani (10.1016/j.bbrc.2017.08.090_bib7) 2015; 11
Yuan (10.1016/j.bbrc.2017.08.090_bib18) 2017; 89
Bo (10.1016/j.bbrc.2017.08.090_bib12) 2014; 7
Naldini (10.1016/j.bbrc.2017.08.090_bib3) 2012; 12
Liu (10.1016/j.bbrc.2017.08.090_bib17) 2000; 27
Solov'Eva (10.1016/j.bbrc.2017.08.090_bib31) 2014; 40
Kamba (10.1016/j.bbrc.2017.08.090_bib10) 2007; 96
Liu (10.1016/j.bbrc.2017.08.090_bib20) 2013; 44
Bussolino (10.1016/j.bbrc.2017.08.090_bib25) 1997; 22
Wang (10.1016/j.bbrc.2017.08.090_bib29) 2006; 118
Kwok (10.1016/j.bbrc.2017.08.090_bib13) 2012; 83
Folkman (10.1016/j.bbrc.2017.08.090_bib1) 1972; 175
Tong (10.1016/j.bbrc.2017.08.090_bib14) 1992; 112
Goodwin (10.1016/j.bbrc.2017.08.090_bib22) 2007; 74
Pratheeshkumar (10.1016/j.bbrc.2017.08.090_bib28) 2011; 668
Mabeta (10.1016/j.bbrc.2017.08.090_bib4) 2009; 12
Carmeliet (10.1016/j.bbrc.2017.08.090_bib23) 1999
Ferrara (10.1016/j.bbrc.2017.08.090_bib26) 2002; 2
Arrighetti (10.1016/j.bbrc.2017.08.090_bib2) 2015; 20
Bono (10.1016/j.bbrc.2017.08.090_bib8) 2013; 23
Funakoshi (10.1016/j.bbrc.2017.08.090_bib5) 2013; 39
Chen (10.1016/j.bbrc.2017.08.090_bib9) 2008; 28
Ashton (10.1016/j.bbrc.2017.08.090_bib21) 1999; 274
References_xml – volume: 118
  start-page: 879
  year: 2006
  end-page: 888
  ident: bib29
  article-title: Vascular endothelial growth factor–regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases[J]
  publication-title: Int. J. Cancer
  contributor:
    fullname: Reierstad
– volume: 96
  start-page: 1788
  year: 2007
  end-page: 1795
  ident: bib10
  article-title: Mechanisms of adverse effects of anti-VEGF therapy for cancer[J]
  publication-title: Br. J. Cancer
  contributor:
    fullname: Mcdonald
– volume: 7
  start-page: 1945
  year: 2014
  end-page: 1954
  ident: bib12
  article-title: Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model[J]
  publication-title: Onco Targets Ther.
  contributor:
    fullname: Yan
– volume: 36
  start-page: 170
  year: 2001
  end-page: 173
  ident: bib19
  article-title: Pharmacokinetics of 20(R)-ginsenoside Rg3 in human volunteers[J]
  publication-title: Yao Xue Xue Bao
  contributor:
    fullname: Fu
– volume: 11
  start-page: 1123
  year: 2015
  end-page: 1132
  ident: bib7
  article-title: Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers.[J]
  publication-title: Ther. Clin. Risk Manag.
  contributor:
    fullname: Abdelrahman
– volume: 668
  start-page: 450
  year: 2011
  end-page: 458
  ident: bib28
  article-title: Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9[J]
  publication-title: Eur. J. Pharmacol.
  contributor:
    fullname: Kuttan
– volume: 82
  start-page: 619
  year: 2001
  end-page: 633
  ident: bib24
  article-title: Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis[J]
  publication-title: J. Cell Biochem.
  contributor:
    fullname: Castelli
– volume: 44
  start-page: 1203
  year: 2013
  end-page: 1210
  ident: bib20
  article-title: Structure modification of dammarane-type ginsenosides (aglycone) focusing on antitumor activities[J]
  publication-title: Chin. Traditional Herb. Drugs
  contributor:
    fullname: Zhao
– start-page: 133
  year: 1999
  end-page: 158
  ident: bib23
  article-title: Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development[M]//vascular growth factors and angiogenesis
  publication-title: Springer Berl. Heidelb.
  contributor:
    fullname: Collen
– volume: 98
  start-page: 119
  year: 2001
  end-page: 124
  ident: bib30
  article-title: Disruption of matrix metalloproteinase 2 binding to integrin αvβ3 by an organic molecule inhibits angiogenesis and tumor growth in vivo[J]
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Goldberg
– volume: 7
  start-page: 133
  year: 2015
  end-page: 143
  ident: bib6
  article-title: Cancer therapy and cardiovascular risk: focus on bevacizumab[J]
  publication-title: Cancer Manag. Res.
  contributor:
    fullname: Kapiris
– volume: 175
  start-page: 409
  year: 1972
  end-page: 416
  ident: bib1
  article-title: Anti-angiogenesis: new concept for therapy of solid tumors[J]
  publication-title: Ann. Surg.
  contributor:
    fullname: Folkman
– volume: 48
  start-page: 163
  year: 2011
  end-page: 170
  ident: bib27
  article-title: Hypoxia in abdominal aortic aneurysm supports a role for HIF-1α and Ets-1 as drivers of matrix metalloproteinase upregulation in human aortic smooth muscle cells[J]
  publication-title: J. Vasc. Res.
  contributor:
    fullname: Winrow
– volume: 20
  start-page: 83
  year: 2015
  end-page: 117
  ident: bib2
  article-title: Drug combinations with HDAC inhibitors in antitumor therapy[J]
  publication-title: Crit. Rev. Oncog.
  contributor:
    fullname: Gatti
– volume: 27
  start-page: 534
  year: 2000
  end-page: 536
  ident: bib17
  article-title: Clinical phase II study on immunoimprovement of patients with breast cancer treated by shenyi capsule[J]
  publication-title: J. Clin. Oncol.
  contributor:
    fullname: Liu
– volume: 29
  start-page: 276
  year: 2002
  end-page: 279
  ident: bib15
  article-title: Phase II clinical trial report of treating lung cancer with Shen Yi capsule[J]
  publication-title: Chin. J. Clin. Oncol.
  contributor:
    fullname: Li
– volume: 39
  start-page: 818
  year: 2013
  end-page: 830
  ident: bib5
  article-title: Risk of hematologic toxicities in cancer patients treated with sunitinib: a systematic review and meta-analysis[J]
  publication-title: Cancer Treat. Rev.
  contributor:
    fullname: Galsky
– volume: 23
  start-page: 477
  year: 2013
  end-page: 488
  ident: bib8
  article-title: Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties[J]
  publication-title: Cancer Cell
  contributor:
    fullname: Herbert
– volume: 83
  start-page: 893
  year: 2012
  end-page: 902
  ident: bib13
  article-title: Stereoisomers ginsenosides-20(S)-Rg
  publication-title: Biochem. Pharmacol.
  contributor:
    fullname: Lau
– volume: 74
  start-page: 172
  year: 2007
  end-page: 183
  ident: bib22
  article-title: In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents[J]
  publication-title: Microvasc. Res.
  contributor:
    fullname: Goodwin
– volume: 12
  start-page: 407
  year: 2012
  end-page: 413
  ident: bib3
  article-title: Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells[J]
  publication-title: Anticancer Agents Med. Chem.
  contributor:
    fullname: Cini
– volume: 89
  start-page: 227
  year: 2017
  end-page: 232
  ident: bib18
  article-title: Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer[J]
  publication-title: Biomed. Pharmacother.
  contributor:
    fullname: Zhu
– volume: 112
  start-page: 856
  year: 1992
  end-page: 865
  ident: bib14
  article-title: Pharmacological study on Panax ginseng C. A. Meyer. XV. Effects of 70% methanolic extract from red and white ginseng on the antitumor activity of mitomycin C[J]
  publication-title: Yakugaku Zasshi
  contributor:
    fullname: Kubo
– volume: 2
  start-page: 795
  year: 2002
  end-page: 803
  ident: bib26
  article-title: VEGF and the quest for tumour angiogenesis factors[J]
  publication-title: Nat. Rev. Cancer
  contributor:
    fullname: Ferrara
– volume: 15
  start-page: 603
  year: 1997
  end-page: 611
  ident: bib11
  article-title: Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats[J]
  publication-title: Clin. Exp. Metastasis
  contributor:
    fullname: Baba
– volume: 40
  start-page: 743
  year: 2014
  end-page: 751
  ident: bib31
  article-title: Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix[J]
  publication-title: Bioorg Khim
  contributor:
    fullname: Kugaevskaia
– volume: 22
  start-page: 251
  year: 1997
  end-page: 256
  ident: bib25
  article-title: Molecular mechanisms of blood vessel formation[J]
  publication-title: Trends Biochem. Sci.
  contributor:
    fullname: Persico
– volume: 28
  start-page: 185
  year: 2008
  end-page: 200
  ident: bib9
  article-title: STAT3: a critical transcription activator in angiogenesis[J]
  publication-title: Med. Res. Rev.
  contributor:
    fullname: Han
– volume: 12
  start-page: 81
  year: 2009
  end-page: 90
  ident: bib4
  article-title: A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents[J]
  publication-title: Angiogenesis
  contributor:
    fullname: Pepper
– volume: 24
  start-page: 61
  year: 2014
  end-page: 66
  ident: bib16
  article-title: Clinical study on intermediate or advanced primary liver cancer by connective and compositive treatment of traditional Chinese and western medicine[J]
  publication-title: Chin. J. Mod. Med.
  contributor:
    fullname: Li
– volume: 274
  start-page: 35562
  year: 1999
  end-page: 35570
  ident: bib21
  article-title: Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A2[J]
  publication-title: J. Biol. Chem.
  contributor:
    fullname: John
– volume: 23
  start-page: 477
  issue: 4
  year: 2013
  ident: 10.1016/j.bbrc.2017.08.090_bib8
  article-title: Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties[J]
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.02.019
  contributor:
    fullname: Bono
– volume: 175
  start-page: 409
  issue: 3
  year: 1972
  ident: 10.1016/j.bbrc.2017.08.090_bib1
  article-title: Anti-angiogenesis: new concept for therapy of solid tumors[J]
  publication-title: Ann. Surg.
  doi: 10.1097/00000658-197203000-00014
  contributor:
    fullname: Folkman
– volume: 12
  start-page: 81
  issue: 1
  year: 2009
  ident: 10.1016/j.bbrc.2017.08.090_bib4
  article-title: A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents[J]
  publication-title: Angiogenesis
  doi: 10.1007/s10456-009-9134-8
  contributor:
    fullname: Mabeta
– volume: 48
  start-page: 163
  issue: 2
  year: 2011
  ident: 10.1016/j.bbrc.2017.08.090_bib27
  article-title: Hypoxia in abdominal aortic aneurysm supports a role for HIF-1α and Ets-1 as drivers of matrix metalloproteinase upregulation in human aortic smooth muscle cells[J]
  publication-title: J. Vasc. Res.
  doi: 10.1159/000318806
  contributor:
    fullname: Erdozain
– volume: 11
  start-page: 1123
  year: 2015
  ident: 10.1016/j.bbrc.2017.08.090_bib7
  article-title: Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers.[J]
  publication-title: Ther. Clin. Risk Manag.
  contributor:
    fullname: Elhalawani
– volume: 96
  start-page: 1788
  issue: 12
  year: 2007
  ident: 10.1016/j.bbrc.2017.08.090_bib10
  article-title: Mechanisms of adverse effects of anti-VEGF therapy for cancer[J]
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6603813
  contributor:
    fullname: Kamba
– volume: 274
  start-page: 35562
  issue: 50
  year: 1999
  ident: 10.1016/j.bbrc.2017.08.090_bib21
  article-title: Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A2[J]
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.274.50.35562
  contributor:
    fullname: Ashton
– volume: 36
  start-page: 170
  issue: 3
  year: 2001
  ident: 10.1016/j.bbrc.2017.08.090_bib19
  article-title: Pharmacokinetics of 20(R)-ginsenoside Rg3 in human volunteers[J]
  publication-title: Yao Xue Xue Bao
  contributor:
    fullname: Pang
– volume: 22
  start-page: 251
  issue: 7
  year: 1997
  ident: 10.1016/j.bbrc.2017.08.090_bib25
  article-title: Molecular mechanisms of blood vessel formation[J]
  publication-title: Trends Biochem. Sci.
  doi: 10.1016/S0968-0004(97)01074-8
  contributor:
    fullname: Bussolino
– start-page: 133
  year: 1999
  ident: 10.1016/j.bbrc.2017.08.090_bib23
  article-title: Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development[M]//vascular growth factors and angiogenesis
  publication-title: Springer Berl. Heidelb.
  contributor:
    fullname: Carmeliet
– volume: 89
  start-page: 227
  year: 2017
  ident: 10.1016/j.bbrc.2017.08.090_bib18
  article-title: Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer[J]
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.02.038
  contributor:
    fullname: Yuan
– volume: 12
  start-page: 407
  issue: 4
  year: 2012
  ident: 10.1016/j.bbrc.2017.08.090_bib3
  article-title: Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells[J]
  publication-title: Anticancer Agents Med. Chem.
  doi: 10.2174/187152012800228706
  contributor:
    fullname: Naldini
– volume: 28
  start-page: 185
  issue: 2
  year: 2008
  ident: 10.1016/j.bbrc.2017.08.090_bib9
  article-title: STAT3: a critical transcription activator in angiogenesis[J]
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.20101
  contributor:
    fullname: Chen
– volume: 7
  start-page: 1945
  year: 2014
  ident: 10.1016/j.bbrc.2017.08.090_bib12
  article-title: Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma rat model[J]
  publication-title: Onco Targets Ther.
  contributor:
    fullname: Bo
– volume: 82
  start-page: 619
  issue: 4
  year: 2001
  ident: 10.1016/j.bbrc.2017.08.090_bib24
  article-title: Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis[J]
  publication-title: J. Cell Biochem.
  doi: 10.1002/jcb.1190
  contributor:
    fullname: Cavallaro
– volume: 74
  start-page: 172
  issue: 2
  year: 2007
  ident: 10.1016/j.bbrc.2017.08.090_bib22
  article-title: In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents[J]
  publication-title: Microvasc. Res.
  doi: 10.1016/j.mvr.2007.05.006
  contributor:
    fullname: Goodwin
– volume: 15
  start-page: 603
  issue: 6
  year: 1997
  ident: 10.1016/j.bbrc.2017.08.090_bib11
  article-title: Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats[J]
  publication-title: Clin. Exp. Metastasis
  doi: 10.1023/A:1018491314066
  contributor:
    fullname: Iishi
– volume: 98
  start-page: 119
  issue: 1
  year: 2001
  ident: 10.1016/j.bbrc.2017.08.090_bib30
  article-title: Disruption of matrix metalloproteinase 2 binding to integrin αvβ3 by an organic molecule inhibits angiogenesis and tumor growth in vivo[J]
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Silletti
– volume: 27
  start-page: 534
  issue: 7
  year: 2000
  ident: 10.1016/j.bbrc.2017.08.090_bib17
  article-title: Clinical phase II study on immunoimprovement of patients with breast cancer treated by shenyi capsule[J]
  publication-title: J. Clin. Oncol.
  contributor:
    fullname: Liu
– volume: 24
  start-page: 61
  issue: 36
  year: 2014
  ident: 10.1016/j.bbrc.2017.08.090_bib16
  article-title: Clinical study on intermediate or advanced primary liver cancer by connective and compositive treatment of traditional Chinese and western medicine[J]
  publication-title: Chin. J. Mod. Med.
  contributor:
    fullname: Lyu
– volume: 40
  start-page: 743
  issue: 6
  year: 2014
  ident: 10.1016/j.bbrc.2017.08.090_bib31
  article-title: Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix[J]
  publication-title: Bioorg Khim
  contributor:
    fullname: Solov'Eva
– volume: 118
  start-page: 879
  issue: 4
  year: 2006
  ident: 10.1016/j.bbrc.2017.08.090_bib29
  article-title: Vascular endothelial growth factor–regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases[J]
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.21421
  contributor:
    fullname: Wang
– volume: 83
  start-page: 893
  issue: 7
  year: 2012
  ident: 10.1016/j.bbrc.2017.08.090_bib13
  article-title: Stereoisomers ginsenosides-20(S)-Rg3 and -20(R)-Rg3 differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma[J]
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2011.12.039
  contributor:
    fullname: Kwok
– volume: 7
  start-page: 133
  year: 2015
  ident: 10.1016/j.bbrc.2017.08.090_bib6
  article-title: Cancer therapy and cardiovascular risk: focus on bevacizumab[J]
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S77400
  contributor:
    fullname: Economopoulou
– volume: 39
  start-page: 818
  issue: 7
  year: 2013
  ident: 10.1016/j.bbrc.2017.08.090_bib5
  article-title: Risk of hematologic toxicities in cancer patients treated with sunitinib: a systematic review and meta-analysis[J]
  publication-title: Cancer Treat. Rev.
  doi: 10.1016/j.ctrv.2013.01.004
  contributor:
    fullname: Funakoshi
– volume: 20
  start-page: 83
  issue: 1–2
  year: 2015
  ident: 10.1016/j.bbrc.2017.08.090_bib2
  article-title: Drug combinations with HDAC inhibitors in antitumor therapy[J]
  publication-title: Crit. Rev. Oncog.
  doi: 10.1615/CritRevOncog.2014012378
  contributor:
    fullname: Arrighetti
– volume: 112
  start-page: 856
  issue: 11
  year: 1992
  ident: 10.1016/j.bbrc.2017.08.090_bib14
  article-title: Pharmacological study on Panax ginseng C. A. Meyer. XV. Effects of 70% methanolic extract from red and white ginseng on the antitumor activity of mitomycin C[J]
  publication-title: Yakugaku Zasshi
  doi: 10.1248/yakushi1947.112.11_856
  contributor:
    fullname: Tong
– volume: 2
  start-page: 795
  issue: 10
  year: 2002
  ident: 10.1016/j.bbrc.2017.08.090_bib26
  article-title: VEGF and the quest for tumour angiogenesis factors[J]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc909
  contributor:
    fullname: Ferrara
– volume: 29
  start-page: 276
  issue: 4
  year: 2002
  ident: 10.1016/j.bbrc.2017.08.090_bib15
  article-title: Phase II clinical trial report of treating lung cancer with Shen Yi capsule[J]
  publication-title: Chin. J. Clin. Oncol.
  contributor:
    fullname: Lin
– volume: 668
  start-page: 450
  issue: 3
  year: 2011
  ident: 10.1016/j.bbrc.2017.08.090_bib28
  article-title: Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9[J]
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2011.07.029
  contributor:
    fullname: Pratheeshkumar
– volume: 44
  start-page: 1203
  issue: 9
  year: 2013
  ident: 10.1016/j.bbrc.2017.08.090_bib20
  article-title: Structure modification of dammarane-type ginsenosides (aglycone) focusing on antitumor activities[J]
  publication-title: Chin. Traditional Herb. Drugs
  contributor:
    fullname: Liu
SSID ssj0011469
Score 2.339836
Snippet This study investigates the anti-angiogenic effect of 3β, 12β, 20(S)-trihydroxy dammarane-3-O-β-d-glucopyranosyl(1–2)-β-d-glucopyranoside(HRG), a new chemical...
This study investigates the anti-angiogenic effect of 3β, 12β, 20(S)-trihydroxy dammarane-3-O-β-d-glucopyranosyl(1-2)-β-d-glucopyranoside(HRG), a new chemical...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 391
SubjectTerms Angiogenesis
Cell proliferation
Cell Proliferation - drug effects
Cells, Cultured
Dose-Response Relationship, Drug
Ginsenoside structure modification
Ginsenosides - chemistry
Human Umbilical Vein Endothelial Cells - drug effects
Humans
HUVECs
Migration
Molecular Conformation
Neovascularization, Pathologic - drug therapy
Saponins - chemical synthesis
Saponins - chemistry
Saponins - pharmacology
Structure-Activity Relationship
VEGF
Title Studies on anti-angiogenesis of ginsenoside structure modification HRG in vitro
URI https://dx.doi.org/10.1016/j.bbrc.2017.08.090
https://www.ncbi.nlm.nih.gov/pubmed/28847727
https://search.proquest.com/docview/1933597387
Volume 492
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BatwwEB2SDSW9hDRp0m2aoELppSixrLHXOm6XpNsWQikN7E3YsrQ4EDtsdgO55Fv6LfmyjGw5EGh76M0WyBYz0ps30mgG4IMqnZTCWo4yKzg66biyEXJUuXWJLImzt9k-z9PpBX6bJbM1mPR3YXxYZcD-DtNbtA4tJ0GaJ9dV5e_4RmmsxEz44kuoCIc3yBwhDmBj_PX79PzpMIHAILDglPsO4e5MF-ZVFAufyVCM2kyeHpr_bJ_-xj9bO3S2DVuBQLJxN8ZXsGbrHdgd1-Q8X92xj6wN6Wz3ynfgxef-aXPSF3bbhR8hdpA1NSO5Vjyv51Uz96BXUaNjfg_a5xCvSsu6_LKrhWVXTenDilpNsunPL6yqH37fVstF8xouzk5_TaY8FFbgRibpkqMQBVEDVMZIJYxysU1ikyc2k46aksQRL4tyTMs8NSWiLMzIGMzK1ElyR5Tcg0Hd1PYNMCywiDK02SjP6bMmI22U5NLQUnfExUZD-NSLU193-TN0H1h2qb3wtRe-9rUwVTSEpJe4fjYLNAH8P_u979WjSZj-zCOvbbO60cRPJflMMqOR7Hd6expHnJFpJv729j__egAv_Zu3ZLF4BwNSiD0kirIsjmD9-F4chYn4CH1u5KU
link.rule.ids 315,786,790,4521,24144,27955,27956,45618,45712
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA6iyHoR32-NIF4k2jZptznqoq6vRWQX9hbaNFkq2C7rruDF3-Jv8Zc504cgqAdvJX2FmXTmm_SbGUIOZGI5d41hgocxE5ZbJo0jmJCRsT5PALMX1T47Qbsnrvt-f4q06lwYpFVWtr-06YW1rkZOKmmeDNMUc3ydwJNu38XmS0KCHZ5BNIC8ruO3L54HZt1WGDhgeHmVOVOSvOJ4hHUM3WZRxxMN88_e6Tf0WXihiwUyX8FHelrOcJFMmWyJLJ9mEDo_vdJDWhA6i53yJTJ7Vh81WnVbt2VyXzEHaZ5RkGrKomyQ5gM0eSkMWoo70FhBPE0MLavLTkaGPuUJkooKPdL2wyVNs4_3l3Q8yldI7-K822qzqq0C09wPxky4bgzAQEituXS1tJ7xPR35JuQWhnzfAipzIhEkUaATIXism1qLMAksh2BE8lUyneWZWSdUxCJ2QmHCZhTBY3UIukggoIEP3QISa26Qo1qcalhWz1A1rexRofAVCl9hJ0zpbBC_lrj6tgYUmPc_79uv1aNAmPjHI8pMPnlWgE45REw8hJmslXr7mocXgmMG9Lb5z7fukUa7e3erbq86N1tkDs-gT_PcbTINyjE7AFbG8W6xGD8Bgjvleg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Studies+on+anti-angiogenesis+of+ginsenoside+structure+modification+HRG+in%C2%A0vitro&rft.jtitle=Biochemical+and+biophysical+research+communications&rft.au=Li%2C+Ji-ping&rft.au=Zhao%2C+Feng-li&rft.au=Yuan%2C+Ye&rft.au=Sun%2C+Ting-ting&rft.date=2017-10-21&rft.pub=Elsevier+Inc&rft.issn=0006-291X&rft.eissn=1090-2104&rft.volume=492&rft.issue=3&rft.spage=391&rft.epage=396&rft_id=info:doi/10.1016%2Fj.bbrc.2017.08.090&rft.externalDocID=S0006291X17316492
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-291X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-291X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-291X&client=summon